Stay updated on Autologous TILs in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Autologous TILs in Metastatic TNBC Clinical Trial page.
Latest updates to the Autologous TILs in Metastatic TNBC Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check24 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check53 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check75 days agoChange DetectedNew efficacy evaluation metrics for autologous LN-145 in Metastatic Triple Negative Breast Cancer patients have been added, focusing on duration of response, disease control rate, median progression-free survival, and overall survival, while several previous metrics have been removed.SummaryDifference6%
Stay in the know with updates to Autologous TILs in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TILs in Metastatic TNBC Clinical Trial page.